Showing results (231-240 of 263) with videos related to
Sort By:
Pageof 27
Genetic Testing|September 12, 2001
Universal newborn screening for Hb H disease in CaliforniaF Lorey, G Cunningham, E P Vichinsky, et al.Lancet (London, England)|August 1, 1987
Endemic goitre in central China caused by excessive iodine intakeM Li, D R Liu, C Y Qu, et al.The Journal of Allergy and Clinical Immunology|March 11, 2017
Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory diseaseJacqueline J Eastman, Kellen J Cavagnero, Adam S Deconde, et al.Lupus Science & Medicine|December 28, 2018
Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC studyRonald F van Vollenhoven, William Stohl, Richard A Furie, et al.Journal of Pharmaceutical Sciences|April 3, 1999
Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing responseJ L Cleland, A Lim, A Daugherty, et al.Asia Pacific Journal of Clinical Nutrition|March 12, 2016
Salt intake and iodine status of women in SamoaMary-Anne Land, Jacqui L Webster, Gary Ma, et al.Inflammatory Bowel Diseases|July 17, 2026
Artificial intelligence assessment of endoscopic severity and extent: A machine learning approach to continuous evaluation of endoscopic inflammation in ulcerative colitisAlvin T George, Klaus Gottlieb, Daniel R Colucci, et al.Science Advances|December 17, 2019
Epigenetic stabilization of DC and DC precursor classical activation by TNFα contributes to protective T cell polarizationAlison J Eastman, Jintao Xu, Jennifer Bermik, et al.Journal of Drug Targeting|April 12, 2000
Cationic lipid structure and formulation considerations for optimal gene transfection of the lungJ Marshall, J B Nietupski, E R Lee, et al.Journal of Crohn'S & Colitis|May 11, 2026
Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trialSilvio Danese, Axel Dignass, David Laharie, et al.Pageof 27